Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Vartiainen

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
The American Journal of Otology|March 1, 1996
The contralateral ear in patients with chronic otitis mediaE Vartiainen, M Kansanen, J Vartiainen
Maturitas|September 1, 1993
Effects and acceptability of a new 17 beta-oestradiol-releasing vaginal ring in the treatment of postmenopausal complaintsJ Vartiainen, T Wahlström, C G Nilsson
European Journal of Obstetrics, Gynecology, and Reproductive Biology|January 1, 1989
Ultrasonography in extended placental retention and intra-uterine adhesions; a case reportJ Vartiainen, P Kajanoja, P R Ylöstalo
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 7, 1999
Skin metastases of gynecologic adenocarcinomas affect serum levels of hCGbeta but not those of SCC antigenP Lehtovirta, H Alfthan, J Vartiainen, et al.
Physical Review Letters|June 4, 2008
Experimental determination of the berry phase in a superconducting charge pumpMikko Möttönen, Juha J Vartiainen, Jukka P Pekola
Physical Review Letters|June 1, 2004
Efficient decomposition of quantum gatesJuha J Vartiainen, Mikko Möttönen, Martti M Salomaa
Physical Review Letters|June 6, 2003
Optimal multiqubit operations for Josephson charge qubitsAntti O Niskanen, Juha J Vartiainen, Martti M Salomaa
Contraception|July 3, 1998
Identification of choriocarcinoma by the hCG beta-to-hCG proportion in patients with delayed diagnosis caused by contraceptive useJ Vartiainen, H Alfthan, P Lehtovirta, et al.
British Journal of Cancer|October 1, 1995
Effect of interleukin 2 on urinary excretion of degradation products of prostacyclin and thromboxane A2 in patients with ovarian cancerA Aitokallio-Tallberg, P Lehtovirta, J Vartiainen, et al.
Annals of Medicine|February 1, 1995
Markers supplementing CA 125 in ovarian cancerU H Stenman, H Alfthan, J Vartiainen, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
The American Journal of Otology|March 1, 1996
The contralateral ear in patients with chronic otitis mediaE Vartiainen, M Kansanen, J Vartiainen
Maturitas|September 1, 1993
Effects and acceptability of a new 17 beta-oestradiol-releasing vaginal ring in the treatment of postmenopausal complaintsJ Vartiainen, T Wahlström, C G Nilsson
European Journal of Obstetrics, Gynecology, and Reproductive Biology|January 1, 1989
Ultrasonography in extended placental retention and intra-uterine adhesions; a case reportJ Vartiainen, P Kajanoja, P R Ylöstalo
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 7, 1999
Skin metastases of gynecologic adenocarcinomas affect serum levels of hCGbeta but not those of SCC antigenP Lehtovirta, H Alfthan, J Vartiainen, et al.
Physical Review Letters|June 4, 2008
Experimental determination of the berry phase in a superconducting charge pumpMikko Möttönen, Juha J Vartiainen, Jukka P Pekola
Physical Review Letters|June 1, 2004
Efficient decomposition of quantum gatesJuha J Vartiainen, Mikko Möttönen, Martti M Salomaa
Physical Review Letters|June 6, 2003
Optimal multiqubit operations for Josephson charge qubitsAntti O Niskanen, Juha J Vartiainen, Martti M Salomaa
Contraception|July 3, 1998
Identification of choriocarcinoma by the hCG beta-to-hCG proportion in patients with delayed diagnosis caused by contraceptive useJ Vartiainen, H Alfthan, P Lehtovirta, et al.
British Journal of Cancer|October 1, 1995
Effect of interleukin 2 on urinary excretion of degradation products of prostacyclin and thromboxane A2 in patients with ovarian cancerA Aitokallio-Tallberg, P Lehtovirta, J Vartiainen, et al.
Annals of Medicine|February 1, 1995
Markers supplementing CA 125 in ovarian cancerU H Stenman, H Alfthan, J Vartiainen, et al.
Pageof 4